Kinetics of sedimentation rate, viral load and TNF-α in relation to HIV co-infection in tuberculosis

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 100, Issue 5, 2006, Pages 483-488

  Schön, Thomas ^a,g   Wolday, Dawit ^b   Elias, Daniel ^c,f   Melese, Endalkachew ^d   Moges, Feleke ^d   Tessema, Tesfaye ^d   Stendahl, Olle ^a   Sundqvist, Tommy ^a   Britton, Sven ^e  

^a LINKÖPING UNIVERSITY   (Sweden)

^b Ethio Netherlands AIDS Research Project ENARP   (Ethiopia)

^c ARMAUER HANSEN RESEARCH INSTITUTE   (Ethiopia)

^d UNIVERSITY OF GONDAR   (Ethiopia)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f KAROLINSKA INSTITUTE   (Sweden)

^g KALMAR COUNTY HOSPITAL   (Sweden)

Author keywords

DOTS; HIV; Sedimentation rate; TNF ; Tuberculosis; Viral load

Indexed keywords

BIOLOGICAL MARKER; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; BLOOD ANALYSIS; CLINICAL FEATURE; CONTROLLED STUDY; ETHIOPIA; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; SEDIMENTATION RATE; SPUTUM SMEAR; TUBERCULOSIS; VIRUS LOAD;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ANTITUBERCULAR AGENTS; BLOOD SEDIMENTATION; ENDEMIC DISEASES; ETHIOPIA; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA; VIRAL LOAD;

ALPHAVIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 33644833968     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2005.07.018     Document Type: Article

References (16)

1. L.G. Bekker G. Maartens L. Steyn G. Kaplan Selective increase in plasma tumor necrosis factor-α and concomitant clinical deterioration after initiating therapy in patients with severe tuberculosis J. Inf. Dis. 178 1998 580-584
2. E.L. Corbett C.J. Watt N. Walker D. Maher B.G. Williams M.C. Raviglione C. Dye The growing burden of tuberculosis. Global trends and interactions with the HIV epidemic Arch. Intern. Med. 103 2003 1009-1020
3. J.S. Friedland J.C. Hartley C.G. Hartley R.J. Shattock G.E. Griffin Cytokine secretion in vivo and ex vivo following chemotherapy of Mycobacterium tuberculosis infection Trans. R. Soc. Trop. Med. Hyg. 90 1996 199-203
4. D. Goletti D. Weissman R.W. Jackson N.M. Graham D. Vlahov R.S. Klein S.S. Munsiff L. Ortona R. Cauda A.S. Fauci Effect of Mycobacterium tuberculosis and HIV replication. Role of immune activation J. Immunol. 157 1996 1271-1278
5. A.D. Harries N.J. Hargreaves J. Kemp A. Jindani D.A. Enarson D. Maher F.M. Salaniponi Deaths from tuberculosis in sub-Saharan African countries with a high prevalence of HIV-1 Lancet 357 2001 1519-1523
6. E. Hedvall Tuberculosis 1964 P.A. Norstedt and Sons Stockholm, Sweden pp. 103-104
7. S.M. Hsieh C.C. Hung M.Y. Chen W.H. Sheng S.C. Chang Dynamics of plasma cytokine levels in patients with advanced HIV infection and active tuberculosis: Implications for early recognition of patients with poor response to anti-tuberculous treatment AIDS 13 1999 935-941
8. S.D. Lawn R.J. Shattock J.W. Acheampong R.B. Lal T.M. Folks G.E. Griffin S.T. Butera Sustained plasma TNF-α and HIV-1 load despite resolution of other parameters of immune activation during treatment of tuberculosis in Africans AIDS 13 1999 2231-2237
9. S.D. Lawn J. Obeng J.W. Acheampong G.E. Griffin Resolution of the acute phase response in West African patients receiving treatment for pulmonary tuberculosis Int. J. Tuberc. Lung Dis. 4 2000 340-344
10. S.D. Lawn S. Wiktor D. Coulibaly A.N. Ackah R.B. Lal Serum C-reactive protein and detection of tuberculosis in persons co-infected with the human immunodeficiency virus Trans. R. Soc. Trop. Med. Hyg. 95 2001 41-42
11. S.D. Lawn S.T. Butera T.M. Shinnick Tuberculosis unleashed: The impact of human immunodeficiency virus infection on the host granulomatous response to Mycobacterium tuberculosis Microbes Infect. 4 2002 635-646
12. L. Morris D.J. Martin L.H. Bredel S.N. Nyoka L. Sacks S. Pendle L. Page-Shipp C.L. Karp T.R. Sterling T.C. Quinn R.E. Chaisson Human immunodeficiency virus-1 RNA levels and CD4 lymphocyte counts, during treatment for active tuberculosis, in South African patients J. Infect. Dis. 187 2003 1967-1971
13. T. Schön D. Elias F. Moges E. Melese T. Tessema O. Stendahl S. Britton T. Sundqvist Arginine supplementation as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis Eur. Respir. J. 21 2003 483-488
14. Z. Toossi H. Mayanja-Kizza C.S. Hirsch K.L. Edmonds T. Spahlinger D.L. Hom H. Aung P. Mugyenyi J.J. Ellner C.W. Whalen Impact of tuberculosis on HIV-1 activity in dually infected patients Clin. Exp. Immunol. 123 2001 223-238
15. D. Wolday B. Hailu A.M. Girm E. Hailu E. Sanders A.L. Fontanet Low CD4+ T-cell count and high HIV viral load precede the development of tuberculosis disease in a cohort of HIV-positive ethiopians Int. J. Tuberc. Lung Dis. 7 2003 110-116
16. R. Wood G. Maartens C.J. Lombard Risk factors for developing tuberculosis in HIV-1 infected adults from communities with a low or very high incidence of tuberculosis J. AIDS 23 2000 75-80